Résultats de la recherche - 9 results
A comparison of COVID-19 incidence rates across six European countries in 2021.
David; Pistol, Adriana; Javiera Rebolledo; Riccardo, Flavia; Riess, Maximilian; Rusu, Lavinia Cipriana; Che, Didier; Coignard, Bruno; COVID-19 Study group; COVID-19 Study Group members Source: Euro ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Antibodies, Viral BNT162 Vaccine Breakthrough Infections COVID-19 COVID-19 Vaccines Humans Immunity nursing homes Population Groups RNA, Messenger SARS-CoV-2 Abstract: BACKGROUND: Nursing home residents, ...
SARS-CoV-2 Surveillance in Belgian Wastewaters
fourth virus wave and were considered complementary and valuable information to conventional epidemiological indicators in the weekly wastewater reports communicated to the National Risk Assessment Group ...
The Relation between Perceived and Actual Understanding and Adherence: Results from a National Survey on COVID-19 Measures in Belgium.
understanding included being male and belonging to a younger age group, while risk factors for actual understanding were speaking French (versus Dutch) and belonging to a lower socio-economic level. Communication ...
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
the prospective multicentre DAWN-plasma trial, adult patients hospitalised with COVID-19 were randomised to 4 units of open-label convalescent plasma combined with standard of care (intervention group ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
admitted to hospital with seasonal hCoV infections by age group. Samples received from week 8, 2020, were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Findings: 2573 primary care ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
absence of an alternative diagnosis. Patients are randomized in a 2:1 ratio to either standard of care and convalescent plasma (active treatment group) or standard of care only. The active treatment group ...
Population vulnerability to COVID-19 in Europe: a burden of disease analysis
70 years and above; and (ii) rate of YLD for COVID-19 vulnerable health conditions across all ages. Bivariate groupings were established for each outcome and combined to establish overall ...
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2.
SARS-CoV-2) data. RST-performance for FP blood and serum was assessed by performing each RST in two groups, namely SARSC oV- 2 positive (n=108) and negative healthcare workers (n=89). Differences in accuracy ...